Skip to main content
. 2015 Sep 28;7(11):1426–1449. doi: 10.15252/emmm.201404976

Figure 5. YAP stimulates expression of EGF-like ligands and EGFR in cervical cancer cell to promote cervical cancer cell proliferation and migration.

Figure 5

  1. RT–PCR results showing that YAP stimulates the mRNA expressions of EGFR, AREG, and TGF-α in ME180 cervical cancer cell. Data were analyzed for significance using one-way ANOVA in GraphPad Prism 5 with Tukey’s post hoc tests. Each bar represents mean ± SEM (= 4). Bars with different letters are significantly different from each other (YAP mRNA: MXIV vs. YAP, = 0.0003; MXIV vs. YAPS127A, = 0.0001; EGFR mRNA: MXIV vs. YAP, = 0.0066; MXIV vs. YAPS127A, = 0.0003; TGF-α mRNA: MXIV vs. YAP, = 0.0235; MXIV vs. YAPS127A, = 0.0040; AREG mRNA: MXIV vs. YAP, = 0.0002; MXIV vs. YAPS127A, < 0.0001).
  2. Proliferation of ME180 cells incubated in medium containing 1% FBS in the absence (control) or presence of 10 ng/ml TGF-α. Data were analyzed with unpaired t-test in GraphPad Prism 5 with Welch’s correction. Each point represents the mean ± SEM of four independent repeats. ***< 0.0001 versus control on day 5.
  3. TGF-α treatment (10 ng/ml, 24 h) promotes ME180 cell cycle progression. G1, S, and G2 indicate cells in G1 phase, DNA synthesis phase, and the G2/M phase, respectively, of cell cycle. Apo: apoptotic cells.
  4. Representative images showing the morphology of ME180 cells with or without TGF-α (10 ng/ml) treatment for 24 h (scale bar: 50 μm) or 108 h (scale bar: 25 μm). Please note the elongation of ME180 cells after TGF-α treatment for 24 h (TGF-α, 24 h) and the formation of multiple layers in ME180 cells after TGF-α treatment for 108 h (TGF-α, 108 h).
  5. Effect of TGF-α on the migration of ME180 cells. TGF-α treatment (100 ng/ml, 10 h) drastically stimulated the migration of ME180 cells.

Source data are available online for this figure.